Novartis sells parts of Sandoz US to India's Aurobindo for $900 mln
September 06, 2018 at 00:01 AM EDT
Novartis AG said on Thursday it would sell the dermatology and generic U.S. oral solids portfolios of Sandoz U.S. to India's Aurobindo Pharma Ltd for $900 million, as the Swiss drugmaker looks to focus on higher growth areas.
